Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
with an international reputation for excellence. The Department has a substantial research programme, with major funding from Medical Research Council (MRC), Wellcome Trust and National Institute
-
Brian Nicholson (Cancer Theme). The successful applicant will be Stats lead for the EBHC DPhil programme and Methodological lead for the Cancer Theme. Responsibilities will include providing strategic
-
conventional boundaries and pursue hypothesis-led science. We will make every effort to support the successful candidate to research independence through the programme, and with training and mentoring
-
The Department of Earth Sciences, University of Oxford, seeks to appoint a full-time Postdoctoral Research Assistant in Active Faulting and Earthquake Hazards. The post holder will report to Prof
-
Calinescu and Prof Doyne Farmer. The postholder will work in the Department of Computer Science at the University of Oxford, based in the Wolfson Building, Parks Road, Oxford. The project is intended
-
assist in coordinating aspects of this complex, multi-institutional research programme. With a current PhD/DPhil (or close to completion) in chemistry, biology, or a related field, you will have
-
and science exploitation of the MIGHTEE survey data. The postholder would have the opportunity to identify new discoveries in the data and would be ideally placed to lead the science based on the data
-
base, the partnership will bring together the University of Oxford’s expertise in statistics, mathematics, engineering and AI with industry scientists. Within the partnership, small research teams will
-
Prof Yarin Gal. The postholder will work in the Department of Computer Science at the University of Oxford, based in the Wolfson Building, Parks Road, Oxford. The postholder is expected to conduct
-
, computational modelling, and in vivo physiology—to dissect cholesterol‑mediated modulation of key receptors like Glucagon receptor and GLP‑1R, with direct relevance to metabolic disease therapeutics. The Siebold